Exact Mass: 530.1691234

FT-0772130

Icariside I

3,5-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-4-one

Macrocycle

4,18-bis(butan-2-yl)-7-methyl-6-oxa-13,20-dithia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1^{5,8}.1^{12,15}]tetracosa-1(21),5(24),7,12(23),14,19(22)-hexaene-2,9,16-trione

C24H30N6O4S2 (530.176986)

curcumin monoglucoside

5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(3-methoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)hepta-1,4,6-trien-3-one

Curcumin monoglucoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Curcumin monoglucoside can be found in a number of food items such as acerola, other bread, shallot, and jujube, which makes curcumin monoglucoside a potential biomarker for the consumption of these food products.

Icariin I

3,5-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one

Icariside I is a natural product found in Epimedium pubescens, Epimedium grandiflorum, and other organisms with data available. Icariside I is a metabolite of Icarlin, which could regulate bone remodeling and is recognized as an effective agent for the treatment of osteoporosis. Icariside I is a metabolite of Icarlin, which could regulate bone remodeling and is recognized as an effective agent for the treatment of osteoporosis.

Icarisid

3,5-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one

Isoswertisin 2-O-(2-methylbutyrate)

2- (4-Hydroxyphenyl) -5-hydroxy-7-methoxy-8- [ 2-O- (2-methylbutyryl) -beta-D-glucopyranosyl ] -4H-1-benzopyran-4-one

3-O-2-Methylbutyrylisoswertisin

Isoswertisin 3-O-(2-methylbutyrate)

Antibiotic PA 42702A

C24H26N4O10 (530.1648856)

Pikuroside

Caohuoside C

3- [ (6-Deoxy-alpha-L-mannopyranosyl) oxy ] -5,7-dihydroxy-2- (3-hydroxy-4-methoxyphenyl) -8- (3-methyl-2-butenyl) -4H-1-benzopyran-4-one

Icariside I

3,5-Dihydroxy-4-methoxy-7- (beta-D-glucopyranosyloxy) -8- (3-methyl-2-butenyl) flavone

Icariside I is a metabolite of Icarlin, which could regulate bone remodeling and is recognized as an effective agent for the treatment of osteoporosis. Icariside I is a metabolite of Icarlin, which could regulate bone remodeling and is recognized as an effective agent for the treatment of osteoporosis.

2,2-Di-(2-phenylethyl)-8,6-dihydroxy-5,5-bichromone (AH11)|6,8-Dihydroxy-2,2-bis(2-phenylethyl)[5,5-bi-4H-1-benzopyranl]-4,4-dione

C34H26O6 (530.1729296000001)

toonaciliatin I

Tetra-Ac-Virginioside

2-O-acetyl-3-O-(E)-p-coumaroylsucrose|mumeose A

3-(4-O-beta-D-glucopyranosylferuloyl)quinic acid

3-O-demethyl mutactimycin

urphoside A

C19H26N6O12 (530.1608636000001)

Ezomycin A2|Ezomycin C1

5-hydroxy-6-methoxy-2-methylchromone-7-O-rutinoside

A disaccharide derivative that consists of 5,7-dihydroxy-6-methoxy-2-methylchromone substituted by a rutinosyl group at position 7 via a glycosidic linkage. Isolated from Crossosoma bigelovii, it exhibits antineoplastic activity.

Neoicariin

5-methoxywikstromol triacetate

Phellodenol H O-hexoside

C27H30O11

NCGC00384818-01_C27H30O11_

Cys Phe Met Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid

Cys Met Phe Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

Cys Met Met Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

Phe Cys Met Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid

Phe Met Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

Phe Met Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

Met Cys Phe Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

Met Cys Met Phe

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

Met Phe Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

Met Phe Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

Met Met Cys Phe

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

Met Met Phe Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

Isoswertisin 3-O-(2-methylbutyrate)

Chloro[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]silver

C27H36AgClN2 (530.1617816)

Radotinib

C27H21F3N8O (530.1790332)

C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor

AMP-N-epsilon-(N-alpha-acetyl lysine methyl ester) 5-phosphoramidate

C19H29N7O9P- (530.1764294)

(1E,4Z,6E)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-7-[3-methoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]hepta-1,4,6-trien-3-one

8-Prenylquercetin 4-methyl ether 3-rhamnoside

(2s,3r,4s,5s,6r)-2-{[4-(2h-1,3-benzodioxol-5-yl)-2-(hydroxymethyl)-6,7-dimethoxy-3-methylnaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(8r,10s)-6,8,11-trihydroxy-1-methoxy-2,8-dimethyl-10-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-9,10-dihydro-7h-tetracene-5,12-dione

(1'r,2s,3'r,8'r,19'e,21'z,25'r,26's)-14',26'-dimethyl-11',18',23'-trioxo-2',10',13',17',24'-pentaoxaspiro[oxirane-2,27'-pentacyclo[23.2.1.0³,⁸.0⁸,²⁶.0¹²,¹⁴]octacosane]-4',19',21'-triene-5'-carboxylic acid

(1'r,2s,3'r,8'r,19'e,21'z,25'r,26's)-14',26'-dimethyl-11',18',23'-trioxo-2',10',13',17',24'-pentaoxaspiro[oxirane-2,27'-pentacyclo[23.2.1.0³,⁸.0⁸,²⁶.0¹²,¹⁴]octacosane]-4',19',21'-triene-5'-carboxylic acid

5-hydroxy-6-methoxy-2-methyl-7-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]chromen-4-one